Immune markers for monitoring the progression of autoimmune disease (Q33654261)

28 July 2017

1 reference

title

Immune markers for monitoring the progression of autoimmune disease (English)

1 reference

28 July 2017

1 reference

N C Schloot

1

1 reference

PubMed ID

10362461

28 July 2017

P Pozzilli

series ordinal

2

1 reference

PubMed ID

10362461

28 July 2017

T Mandrup-Poulsen

series ordinal

3

1 reference

28 July 2017

1 March 1999

1 reference

Diabetes - Metabolism: Research and Reviews

28 July 2017

1 reference

28 July 2017

15

1 reference

28 July 2017

2

1 reference

28 July 2017

141-145

1 reference

Immunopathology of human inflammatory bowel disease

28 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Immune-mediated demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Value of magnetic resonance imaging in assessing efficacy in clinical trials of multiple sclerosis therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

T-cell epitope mapping by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Regional differences in the incidence of insulin-dependent diabetes mellitus among children in Finland from 1987 to 1991. Childhood Diabetes in Finland (DiMe) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

T-cell responses to autoantigens in IDDM. The search for the Holy Grail

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

The pathogenesis of insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Mediators of inflammation in chronic inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 123I-interleukin-2: an early sign of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199903%2F04%2915%3A2%3C141%3A%3AAID-DMRR19%3E3.0.CO%3B2-A

10.1002/(SICI)1520-7560(199903/04)15:2<141::AID-DMRR19>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10362461